The value of fluorescence-based mIHC combined with DIA technology for colocalization analyses [29] has been well demonstrated in immunoprofiling studies [9, 19, 30–32], and we illustrate the feasibility of such analyses also for assessing the relationship between important tumor differentiation markers such as CDX2 and SOX2. The gene discussed is CDX2; the disease is neoplasm.